UBS Raises price Target on PerkinElmer (PKI) to $61; Reiterates Buy

September 22, 2016 9:21 AM EDT
Get Alerts PKI Hot Sheet
Price: $55.53 -0.14%

Rating Summary:
    9 Buy, 12 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 15 | Down: 13 | New: 71
Trade PKI Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

UBS reiterated a Buy rating on PerkinElmer (NYSE: PKI), and raised the price target to $61.00 (from $56.00). Recent management commentary reaffirms continued confidence in PKI’s ability to achieve its 22% operating margin target by 2020.

Analyst Jonathan Groberg commented, "As we highlighted in our recent sector note, Life Science & Dx Tools stocks have maintained their rally in 2016 as absolute NTM P/E multiples continue to expand. Against this sector backdrop, we believe PKI offers an underappreciated favorable risk/reward as the stock continues to trade at a discount even as management continues to demonstrate it can deliver on long-term financial targets. We are increasing our price target to $61 reflecting higher peer multiples and continued conviction in our thesis."

For an analyst ratings summary and ratings history on PerkinElmer click here. For more ratings news on PerkinElmer click here.

Shares of PerkinElmer closed at $54.29 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

UBS

Add Your Comment